-
Sep 20, 2022, 8:31 pm240 pts
MuggleheadMind Medicine Inc. (NASDAQ: MNMD), (NEO: MMED) has now dosed its first patient in a new study aimed at assessing the qualities and effects of a series of MDMA-like substances. On Tuesday, the New-York based biopharmaceutical company announced that it had successfully administered MDMA, MDA, Lys-MDMA, Lys-MDA…
Trending Today on NewsBudz
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
